Amar Remedies has target of Rs 98: Ashish Tater

Amar Remedies has target of Rs 98, says Ashish Tater of Fort Share Broking

Tater told CNBC-TV18, "Amar Remedies has got  tremendous potential in the long term. But it is showing quite a resistance around Rs 110 -120 odd mark. I am playing for an intraday target of close to Rs 98." The company's trailing 12-month (TTM) EPS was at Rs 14.14 per share. (Mar, 2011). The stock's price-to-earnings (P/E) ratio was 6.65. The latest book value of the company is Rs 68.72 per share. At current value, the price-to-book value of the company was 1.37. The dividend yield of the company was 1.06%. Click HERE to know the rules and follow the score card